Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Hapibev Paediatric Vaccine 0.5 ml

Hapibev Paediatric Vaccine 0.5 ml is an inactivated Hepatitis A vaccine used to prevent hepatitis A infection in children. It helps the immune system produce antibodies that protect against the hepatitis A virus, which is typically spread through contaminated food or water and close contact with infected individuals.

In stock
SKU
SBHA06554
Price: 0.00 (Inclusive of Taxable Goods)
Hapibev Paediatric Vaccine 0.5 ml is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Contains inactivated Hepatitis A virus antigen

  • Pediatric formulation suitable for children

  • Helps prevent infection both pre- and post-exposure (within 2 weeks)

  • Booster dose may be needed for long-term protection

  • Administered only by trained healthcare professionals

  • Recommended for high-risk individuals (travelers, immunocompromised, close contacts)

  • Mild and temporary side effects in most cases

  • Supports public health efforts in hepatitis A endemic areas

Technical Details
Technical Specification
  • Dosage Form: Injectable suspension

  • Volume per Dose: 0.5 ml

  • Active Ingredient: Inactivated Hepatitis A virus antigen

  • Route of Administration: Intramuscular injection

  • Indication: Prevention of Hepatitis A

  • Target Group: Children; may also be used in other age groups under medical guidance

  • Storage: 2°C to 8°C; do not freeze

  • Shelf Life: As indicated on packaging (typically 2–3 years if stored properly)

  • 0.5 ml Injection
  • Provides early and effective protection against Hepatitis A

  • Safe for use in children and other vulnerable populations

  • A single dose provides immediate short-term immunity; booster enhances long-term protection

  • Reduces the risk of outbreaks, especially in daycare, healthcare, and travel settings

  • Can prevent serious liver complications associated with HAV

  • Well-tolerated with minimal adverse effects

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.